NovoCure Limited Reports Preliminary, Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2021
For the year, the company reported net revenues of $535 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.23 USD | -0.89% | +1.49% | -18.08% |
1st Jan change | Capi. | |
---|---|---|
-18.08% | 1.32B | |
+72.64% | 12.34B | |
-18.30% | 7.96B | |
+15.38% | 7.16B | |
+3.97% | 5.72B | |
+6.51% | 5.03B | |
+21.99% | 4.35B | |
-21.67% | 3.99B | |
-41.36% | 2.21B | |
+0.87% | 2.01B |